| Patient Care |
|
| Pharmacogenomics task force identifies genetic variants with implications for drug therapy
In a key innovation developed by a Mayo task force, if a patient is at risk of a drug-gene interaction, a warning appears when the clinician enters the prescribed medication into the patient's EMR.
|
| Research |
|
|
Pharmacogenomic testing may improve treatment for patients with depression
A new Mayo Clinic study explores whether pharmacogenomic testing should be part of regular clinical practice — before antidepressant therapy starts — to minimize the number of unsuccessful medication trials for patients with depressive disorder.
Study explores SSRI action at the molecular level in patients with MDD
Mayo researchers have performed the first genome-wide association study for plasma concentrations of escitalopram and its metabolites in patients with major depressive disorder who were treated with the medication.
See all Psychiatry and Psychology Clinical Trials at Mayo Clinic
|
| Back To Top |
| Education |
|
|
Psychiatry in Medical Settings
Jan. 22-24, 2015, in New Orleans
Mayo Clinic faculty will review principles of psychiatric diagnosis and treatment of patients in medical and surgical inpatient and outpatient settings.
Aeschi 8: Bearing the Struggle: Exploring the Challenges Facing Clinicians Working with Suicidal Patients
June 11-13, 2015, in Vail, Colorado
This videotape-based workshop in suicide assessment and treatment helps attendees understand the experiences of the suicidal patient and the responses of the therapist to that patient's narrative. In each scenario, patient and therapist will co-construct an appropriate treatment plan.
See all Psychology & Psychiatry Continuous Professional Development Courses |
| Back To Top |
In the Video Center |
|
|
Somatic Symptoms Disorders, Part I: New Terminology for New Concepts
Jeffrey P. Staab, M.D., discusses the concepts that led to the development of the new terminology for the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5).
Part II: Core Features and Treatment
Part III: Fallacy of Medically Unexplained Thinking
View videos by specialty and Grand Rounds presentations online |
| Back
To Top |
Consults & Referrals |
|
|
|
| Back To Top |
| Resources |
|
|
|
| Back To Top |
|
|
|
|
|
